Delivery system for the enhanced efficiency of immunostimulatory nucleic acids

Innate Immunity

Volumn 19, Issue 1, 2013, Pages 53-65

  Smole, Anže ^a   Krajnik, Alenka Kužnik ^a   Oblak, Alja ^a   Pirher, Nina ^a   Jerala, Roman ^a,b  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cancer; immunostimulatory nucleic acids; receptor mediated endocytosis; Toll like receptors; transferrin

Indexed keywords

IMMUNOSTIMULATORY NUCLEIC ACID; INTERLEUKIN 6; NUCLEIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID; POLYLYSINE; RIBONUCLEASE; TOLL LIKE RECEPTOR 3; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; ENDOCYTOSIS; ENDOSOME; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE;

ADJUVANTS, PHARMACEUTIC; DRUG DELIVERY SYSTEMS; ENDOSOMES; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; IMMUNIZATION; INFECTION; NUCLEIC ACIDS; POLY I-C; POLYLYSINE; PROTEIN TRANSPORT; RECEPTORS, TRANSFERRIN; TOLL-LIKE RECEPTOR 3; TRANSFERRIN; VACCINES;

EID: 84872378166     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912450346     Document Type: Article

References (46)

1. Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol. 2007 ; 5: 505-517
2. Gay NJ, Gangloff M. Structure and function of Toll receptors and their ligands. Annu Rev Biochem. 2007 ; 76: 141-165
3. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006 ; 124: 783-801
4. Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol. 2008 ; 180: 3399-3405
5. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun. 2002 ; 293: 1364-1369
6. Hewson CA, Jardine A, Edwards MR, Laza-stanca V, Johnston SL. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J virol. 2005 ; 79: 12273-12279
7. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 2008 ; 452: 591-597
8. Matsumoto M, Seya T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev. 2008 ; 60: 805-812
9. Seya T, Matsumoto M. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol Immunother. 2009 ; 58: 1175-1184
10. Schulz O, Diebold SS, Chen M, Naslund TI, Nolte MA, Alexopoulou L, et al. Toll-like receptor 3 promotes cross- priming to virus-infected cells. Nature. 2005 ; 433: 887-892
11. Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, et al. Cross-priming of CD8 + T cells stimulated by virus-induced type I interferon. Nat Immunol. 2003 ; 4: 1009-1015
12. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity. 2007 ; 26: 503-517
13. Akazawa T, Ebihara T, Okuno M, Okuda Y, Shingai M, Tsujimura K, et al. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci USA. 2007 ; 104: 252-257
14. Zaks K, Jordan M, Guth A, Sellins K, Kedl R, Izzo A, et al. Adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J Immunol. 2006 ; 176: 7335-7345
15. Ichinohe T, Watanabe I, Ito S, Fujii H, Moriyama M, Tamura S-ichi, et al. Synthetic double-stranded RNA poly (I: C) combined with mucosal vaccine protects against influenza virus infection. J virol. 2005 ; 79: 2910-2919
16. Melief CJM. Cancer immunotherapy by dendritic cells. Immunity. 2008 ; 29: 372-383
17. Jasani B, Navabi H, Adams M. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer. Vaccine. 2009 ; 27: 3401-3404
18. Salaun B, Coste I, Rissoan M-C, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol. 2006 ; 176: 4894-4901
19. Kuznik A, Panter G, Jerala R. Recognition of nucleic acids by Toll-like receptors and development of immunomodulatory drugs. Curr Med Chem. 2010 ; 17: 1899-1914
20. Xie H, Gursel I, Ivins BE, Singh M, Hagan DTO, Ulmer JB, et al. CpG Oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine. Infect Immun. 2005 ; 73: 828-833
21. Qian ZM, Li H, Sun H, Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol rev. 2002 ; 54: 561-587
22. Inoue T, Cavanaugh PG, Steck PA, Brünner N, Nicolson GL. Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials. J Cell Physiol. 1993 ; 156: 212-217
23. Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Stability of poly(L-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment. Pharm Dev Technol. 1999 ; 4: 491-498
24. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA. 1990 ; 87: 3410-3414
25. Carlsson J, Drevin H, Axén R. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J. 1978 ; 173: 723-737
26. Kim T-G, Kang S-Y, Kang J-H, Cho M-Y, Kim J-I, Kim S-H, et al. Gene transfer into human hepatoma cells by receptor-associated protein/polylysine conjugates. Bioconjug Chem. 2004 ; 15: 326-332
27. Holder JW, Lingrel JB. Determination of secondary structure in rabbit globin messenger RNA by thermal denaturation. Biochemistry. 1975 ; 14: 4209-4215
28. de Clercq E. Degradation of poly(inosinic acid)-poly(cytidylic acid) [(I)n-(C)n] by human plasma. Eur J Biochem. 1979 ; 93: 165-172
29. Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov. 2006 ; 5: 471-484
30. Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM, et al. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci USA. 2005 ; 102: 10976-10980
31. Choe J, Kelker MS, Wilson IA. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science. 2005 ; 309: 581-585
32. Pirher N, Ivicak K, Pohar J, Bencina M, Jerala R. A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation. Nat Struct Mol Biol. 2008 ; 15: 761-763
33. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol. 2004 ; 5: 190-198
34. Johnsen IB, Nguyen TT, Ringdal M, Tryggestad AM, Bakke O, Lien E, et al. Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J. 2006 ; 25: 3335-3346
35. Krishnamachari Y, Salem AK. Innovative strategies for co-delivering antigens and CpG oligonucleotides. Adv Drug Deliv Rev. 2009 ; 61: 205-217
36. Wagner E, Curiel D, Cotten M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv Drug Deliv Rev. 1994 ; 14: 113-135
37. Wagner E, Ogris M, Zauner W. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv Drug Deliv Rev. 1998 ; 30: 97-113
38. Citro G, Perrotti D, Cucco C, D'Agnano I, Sacchi A, Zupi G, et al. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA. 1992 ; 89: 7031-7035
39. Bleil JD, Bretscher MS. Transferrin receptor and its recycling in HeLa cells. EMBO J. 1982 ; 1: 351-355
40. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y-H, Homey B, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007 ; 449: 564-569
41. Sasai M, Linehan MM, Iwasaki A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science. 2010 ; 329: 1530-1534
42. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 2009 ; 462: 99-103
43. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med. 2006 ; 203: 413-424
44. Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science. 2004 ; 304: 1014-1018
45. Blander JM. Signalling and phagocytosis in the orchestration of host defence. Cell Microbiol. 2007 ; 9: 290-299
46. Blander JM. Coupling Toll-like receptor signaling with phagocytosis: potentiation of antigen presentation. Trends Immunol. 2007 ; 28: 19-25